Linea System
LINEA System, founded in 2008, aims to eliminate challenges in traditional clinical trial start-up models by streamlining site identification, feasibility, and activation. They leverage AI and their proprietary platform, AcceleTrial®, which combines objective and subjective data with AI-enabled algorithms to access, normalize, and integrate key site-level insights. Supported by a global network of over 300,000 investigators and research sites, LINEA System builds customized site identification strategies tailored to each protocol, ensuring the selection of the right sites with access to the right patients to secure enrollment. Their solution results in improved sponsor and site satisfaction, reduced time to selection and activation, and a more efficient path to trial success. They serve Top 5 Pharma companies, as well as mid-tier and small, start-up Biotech companies, offering a tailored and flexible approach.
Linea System
LINEA System, founded in 2008, aims to eliminate challenges in traditional clinical trial start-up models by streamlining site identification, feasibility, and activation. They leverage AI and their proprietary platform, AcceleTrial®, which combines objective and subjective data with AI-enabled algorithms to access, normalize, and integrate key site-level insights. Supported by a global network of over 300,000 investigators and research sites, LINEA System builds customized site identification strategies tailored to each protocol, ensuring the selection of the right sites with access to the right patients to secure enrollment. Their solution results in improved sponsor and site satisfaction, reduced time to selection and activation, and a more efficient path to trial success. They serve Top 5 Pharma companies, as well as mid-tier and small, start-up Biotech companies, offering a tailored and flexible approach.